|Articles|November 1, 2012
- Pharmaceutical Executive-11-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - November 2012
Pharm Exec's 2013 Pipeline Report
Advertisement
Articles in this issue
over 13 years ago
Europe's Trust Gapover 13 years ago
Who Pays for Specialty Medicines?over 13 years ago
OTC Crunch Time in Californiaover 13 years ago
Prix Galien: Night at the Museumover 13 years ago
Real World Insightsover 13 years ago
Simple Questions for Spainover 13 years ago
Market Access Roadmapover 13 years ago
Pharm Exec's 2013 Pipeline Reportover 13 years ago
Country Report: Czech RepublicAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5